Cost-effectiveness of biologics in polya
β
Wendy J. Ungar; Vania Costa; Rebecca Hancock-Howard; Brian M. Feldman; Ronald M.
π
Article
π
2010
π
Wiley (John Wiley & Sons)
π
English
β 150 KB
π 2 views
## Abstract ## Objective Juvenile idiopathic arthritis (JIA) is the most common chronic pediatric rheumatic disease and can have longβterm effects leading to disability in adulthood. Biologics are a new class of drugs increasingly used to treat JIA. The primary study objective was to determine the